What happens to the brain when we die?
The doctors will not say it, but you can tell by their eyes, and those of your family and...
lung cancer
Management of rare mutations in non-small cell lung cancer (NSCLC) – PART 1: MET, ROS1, and ALK
Why do we make a fuss about rare mutations in NSCLC? In 2015, they only made up about 1-2%...
Lung Cancer – Navigating through the maze
When it comes to lung cancer, the patient and the physician often feel like Danny in The Shining, navigating...
First-in-class drug approved for bone marrow protection during chemotherapy
Chemotherapy can be lifesaving, but it can also damage bone marrow and cause blood cell counts to drop, sometimes...